SLC52A3 and gastric adenocarcinoma: The expression of SLC52A3 in early-stage STAD tissues was significantly higher than that in normal tissues, while the expression of the other 9 DEGs in early-stage STAD tissues was significantly lower than that in normal tissues (P < 0.001, Table 2).